✦ LIBER ✦

A 82Rb infusion system for quantitative perfusion imaging with 3D PET

✍ Scribed by Neil J. Epstein; Ahmed Benelfassi; Rob S.B. Beanlands; Robert A deKemp

Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 450 KB
Volume: 60
Category: Article
ISSN: 0969-8043
DOI: 10.1016/j.apradiso.2004.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Construction and tests of demonstrator m

Construction and tests of demonstrator modules for a 3-D axial PET system for brain or small animal imaging

✍ P. Beltrame; E. Bolle; A. Braem; C. Casella; E. Chesi; N. Clinthorne; E. Cochran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 719 KB

QUIPSS II with thin-slice TI1 periodic s

QUIPSS II with thin-slice TI1 periodic saturation: A method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling

✍ Wen-Ming Luh; Eric C. Wong; Peter A. Bandettini; James S. Hyde 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Comparison of ultrafast dipyridamole mag

Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole sestamibi SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: Assessment by quantitative model fitting

✍ Niels A. A. Matheijssen; Hans W. Louwerenburg; F. Paul van Rugge; Ruud Pj. H. Ar 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 789 KB

## Abstract The value of ultrafast MRI for detection of myocardial perfusion abnormalities in patients with coronary artery disease (CAD) was assessed in 10 patients with stable angina pectoris and angiographically proven one‐vessel CAD using double‐level short‐axis ultrafast MRI with bolus injecti

Radiosynthesis of (S)-5-methoxymethyl-3-

Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET

✍ Yann Bramoullé; Frédéric Puech; Wadad Saba; Heric Valette; Michel Bottlaender; P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB

## Abstract Within a novel series of 2‐oxazolidinones developed in the past by Sanofi‐Synthélabo, SL25.1188 ((__S__)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[__d__]isoxazol‐3‐yl]oxazolidin‐2‐one), a compound that inhibits selectively and competitively MAO‐B in human and rat brain (Ki value